Cellect Biotechnology Ltd (APOP.OQ)
APOP.OQ on NASDAQ Stock Exchange Capital Market
4.97USD
17 Aug 2018
4.97USD
17 Aug 2018
Change (% chg)
$-0.03 (-0.60%)
$-0.03 (-0.60%)
Prev Close
$5.00
$5.00
Open
$5.07
$5.07
Day's High
$5.10
$5.10
Day's Low
$4.60
$4.60
Volume
13,393
13,393
Avg. Vol
3,677
3,677
52-wk High
$13.50
$13.50
52-wk Low
$4.40
$4.40
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.00 | -0.046 |
| Mar '18 | 0.00 | -0.028 | |
| FY 2017 | Dec '17 | ||
| Jun '17 | 0.00 | -0.042 | |
| Mar '17 | 0.00 | -0.137 | |
| FY 2016 | Dec '16 | 0.00 | -0.021 |
| Sep '16 | 0.00 | -0.071 | |
| Jun '16 | 0.00 | -0.039 | |
| Mar '16 | 0.00 | -0.049 |
*Note: Units in Millions ofShekel
**Note: Units in Shekel
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 99.36 | 30.45 | |
| P/E High - Last 5 Yrs. | -- | 272.05 | 47.36 | |
| P/E Low - Last 5 Yrs. | -- | 95.21 | 24.74 | |
| Beta | 2.09 | 0.78 | 0.84 | |
| Price to Sales (TTM) | -- | 126.22 | 5.98 | |
| Price to Book (MRQ) | 9.75 | 13.00 | 3.69 | |
| Price to Tangible Book (MRQ) | 8.71 | 22.28 | 5.63 | |
| Price to Cash Flow (TTM) | -- | 64.21 | 20.97 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.37 | 1.78 | |
| Dividend Yield - 5 Year Avg | -- | 0.21 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 2.47 | -5.93 | |
| Payout Ratio(TTM) | -- | 6.14 | 46.55 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 158.89 | 7.18 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 91.20 | 12.05 | |
| Sales - 5 Yr. Growth Rate | -- | 24.34 | 7.61 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -8.41 | 74.27 | 23.85 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 45.80 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 23.23 | 7.52 | |
| Capital Spending - 5 Yr. Growth Rate | 80.20 | 36.95 | 8.06 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.73 | 2.50 |
| Current Ratio (MRQ) | 10.32 | 5.42 | 3.53 |
| LT Debt to Equity (MRQ) | 0.00 | 19.75 | 11.27 |
| Total Debt to Equity (MRQ) | 0.00 | 23.48 | 14.23 |
| Interest Coverage (TTM) | -4.33 | -186.89 | 31.77 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 57.13 | 55.23 | |
| Gross Margin - 5 Yr. Avg. | -- | 52.64 | 53.33 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -189.34 | 15.82 | |
| Operating Margin (TTM) | -- | -673.76 | 3.86 | |
| Operating Margin - 5 Yr. Avg. | -- | -202.74 | 10.95 | |
| Pre-Tax Margin (TTM) | -- | -665.74 | 4.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -203.67 | 11.12 | |
| Net Profit Margin (TTM) | -- | -655.99 | 0.98 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -201.27 | 7.47 | |
| Effective Tax Rate (TTM) | -- | 12.18 | 20.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.69 | 24.15 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 5,071,848 | 718,909,906 | |
| Net Income/Employee (TTM) | -- | -6,208,777 | 83,624,743 | |
| Receivable Turnover (TTM) | -- | 6.39 | 5.38 | |
| Inventory Turnover (TTM) | -- | 2.25 | 3.51 | |
| Asset Turnover (TTM) | 0.00 | 0.42 | 0.83 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -71.73 | 1.88 | 10.04 | |
| Return on Assets - 5 Yr. Avg. | -77.20 | 2.31 | 10.94 | |
| Return on Investment (TTM) | -79.81 | 2.89 | 12.63 | |
| Return on Investment - 5 Yr. Avg. | -87.94 | 1.68 | 14.14 | |
| Return on Equity (TTM) | -111.89 | 1.65 | 14.82 | |
| Return on Equity - 5 Yr. Avg. | -96.80 | -6.94 | 15.50 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -49.97 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Cellect Biotechnology Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.